跳至主要内容
临床试验/EUCTR2020-000890-25-FR
EUCTR2020-000890-25-FR进行中(未招募)1 期

Treatment of Coronavirus SARS-Cov2 Respiratory Infections with Hydroxychloroquine - SARS-CoV2quine

Fondation Méditerranée Infection (FMI) - IHU Méditerranée Infection0 个研究点目标入组 25 人开始时间: 2020年3月10日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Women and men with documented respiratory infection with Coronavirus SARS CoV 2
  • - Teenager girls and boys aged more than 12 years old
  • - Persons who have given their free and informed consent and have signed the written form.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 5
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - Pregnant woman
  • -Child less than 12 years-old
  • -Known hypersensitivity to chloroquine or hydroxy chloroquine.
  • -Retinopathy
  • -Known deficit in G6PD
  • -Refusal to participate in the study
  • -Patient with known QT prolongation

研究者

发起方
Fondation Méditerranée Infection (FMI) - IHU Méditerranée Infection

相似试验